Combination of furosemide, gold, and dopamine as a potential therapy for breast cancer

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Functional & Integrative Genomics

• Publication date

  2023-03-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10142-023-01007-1PMID 36943579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Application value of circulating LncRNA in diagnosis, treatment, and prognosis of breast cancer

  2023cited by this paper
• Mutational Impacts on the N and C Terminal Domains of the MUC5B Protein: A Transcriptomics and Structural Biology Study

  2023cited by this paper
• Ranking Breast Cancer Drugs and Biomarkers Identification Using Machine Learning and Pharmacogenomics.

  2023cited by this paper
• Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer

  2023cited by this paper
• LINC02381 suppresses cell proliferation and promotes apoptosis via attenuating IGF1R/PI3K/AKT signaling pathway in breast cancer

  2023cited by this paper
• Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A medicinal chemistry approach

  2022cited by this paper
• In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer

  2022cited by this paper
• Bringing Structural Implications and Deep Learning-Based Drug Identification for KRAS Mutants

  2021cited by this paper
• HD5 and LL-37 Inhibit SARS-CoV and SARS-CoV-2 Binding to Human ACE2 by Molecular Simulation

  2021cited by this paper
• Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer

  2020cited by this paper
• Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer

  2019cited by this paper
• Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Mycobacterium tuberculosis Associated With Pyrazinamide Resistance

  2019cited by this paper
• Review of Drug Repositioning Approaches and Resources

  2018cited by this paper
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study

  2017cited by this paper
• Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity

  2017cited by this paper
• A Review of Computational Drug Repositioning Approaches.

  2017cited by this paper
• Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data

  2017cited by this paper
• The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.

  2017cited by this paper
• Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

  2017cited by this paper
• Laying in silico pipelines for drug repositioning: a paradigm in ensemble analysis for neurodegenerative diseases.

  2017cited by this paper
• Surface proteome mining for identification of potential vaccine candidates against Campylobacter jejuni: an in silico approach

  2016cited by this paper
• Cancer statistics in China, 2015

  2016cited by this paper
• Comprehensive tissue-specific gene set enrichment analysis and transcription factor analysis of breast cancer by integrating 14 gene expression datasets

  2016cited by this paper
• Drug response consistency in CCLE and CGP

  2016cited by this paper
• In silico transcriptional regulation and functional analysis of dengue shock syndrome associated SNPs in PLCE1 and MICB genes

  2016cited by this paper
• MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice

  2016cited by this paper
• A survey of current trends in computational drug repositioning

  2016cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines

  2015cited by this paper
• PubChem Substance and Compound databases

  2015cited by this paper
• Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.

  2015cited by this paper
• Expression profiling of circulating tumor cells in metastatic breast cancer

  2014cited by this paper
• LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures

  2014cited by this paper
• Flexible CDOCKER: Development and application of a pseudo‐explicit structure‐based docking method within CHARMM

  2014influential reference
• The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line

  2013cited by this paper
• Transcriptional data: a new gateway to drug repositioning?

  2013cited by this paper
• Genomic Signatures of Pregnancy-Associated Breast Cancer Epithelia and Stroma and their Regulation by Estrogens and Progesterone

  2013cited by this paper
• DrugBank 4.0: shedding new light on drug metabolism

  2013cited by this paper
• Tackling the conformational sampling of larger flexible compounds and macrocycles in pharmacology and drug discovery.

  2013cited by this paper
• Implementing personalized cancer genomics in clinical trials

  2013cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• Using Whole-Genome Sequence Data to Predict Quantitative Trait Phenotypes in Drosophila melanogaster

  2012cited by this paper
• Comprehensive literature review and statistical considerations for microarray meta-analysis

  2012cited by this paper
• Detecting disease-associated genes with confounding variable adjustment and the impact on genomic meta-analysis: With application to major depressive disorder

  2012cited by this paper
• Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis

  2012cited by this paper
• Mod-CSA: Modularity optimization by conformational space annealing

  2012cited by this paper
• Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis

  2011cited by this paper
• Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

  2011cited by this paper
• Probing the α‐Helical Structural Stability of Stapled p53 Peptides: Molecular Dynamics Simulations and Analysis

  2010cited by this paper
• Biomarker detection in the integration of multiple multi-class genomic studies

  2010influential reference
• Cancer Biomarkers: Are We Ready for the Prime Time?

  2010cited by this paper
• Personalized medicine in oncology: tailoring the right drug to the right patient.

  2010cited by this paper
• Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.

  2010cited by this paper
• Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example.

  2010cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• PubChem: a public information system for analyzing bioactivities of small molecules

  2009cited by this paper
• Predicting Unobserved Phenotypes for Complex Traits from Whole-Genome SNP Data

  2008cited by this paper
• The cancer biomarker problem

  2008cited by this paper
• Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement

  2008cited by this paper
• New uses for old drugs

  2007cited by this paper
• Simulated annealing exploration of an active‐site tyrosine in TEM‐1β‐lactamase suggests the existence of alternate conformations

  2007cited by this paper
• DrugBank: a knowledgebase for drugs, drug actions and drug targets

  2007cited by this paper
• Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters

  2006cited by this paper
• Mining microarray data at NCBI's Gene Expression Omnibus (GEO)*.

  2006influential reference
• Extending survival with chemotherapy in metastatic breast cancer.

  2005cited by this paper
• The price of innovation: new estimates of drug development costs.

  2003cited by this paper
• Proteomics: Guilt-by-association goes global

  2000cited by this paper
• LINCS: A linear constraint solver for molecular simulations

  1997influential reference
• Optimization by Simulated Annealing

  1983cited by this paper

• Revolutionizing breast cancer immunotherapy by integrating AI and nanotechnology approaches: review of current applications and future directions

  2025cites this paper
• Exploring the interplay between LDHA and ABCC1 in breast cancer using computational approach

  2025cites this paper
• Advances in genomic and pharmacokinetic profiling for clinical stratification of metastatic breast cancer

  2025cites this paper
• In-silico study unveils potential phytocompounds in Andrographis paniculata against E6 protein of the high-risk HPV-16 subtype for cervical cancer therapy

  2024cites this paper
• Non-coding RNA’s prevalence as biomarkers for prognostic, diagnostic, and clinical utility in breast cancer

  2023cites this paper
• Prognostic models for breast cancer: based on logistics regression and Hybrid Bayesian Network

  2023cites this paper